Metastatic Anal Cancer and Novel Agents

Sep 22, 2017 by in ONCOLOGY Comments Off on Metastatic Anal Cancer and Novel Agents

Squamous cell carcinoma of the anal canal (SCCA) represents an orphan disease. Although prior infection with human papilloma virus is associated with the development of SCCA, knowledge of this relationship…

read more

Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone

Sep 22, 2017 by in ONCOLOGY Comments Off on Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone

The fourth edition of the World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone was published in February 2013. The 2013 WHO volume provides an updated classification…

read more

Contemporary Management and Controversies of Sarcoma

Sep 22, 2017 by in ONCOLOGY Comments Off on Contemporary Management and Controversies of Sarcoma

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA www.surgonc.theclinics.com Consulting Editor NICHOLAS J. PETRELLI October 2016 • Volume 25 • Number 4 Related posts: Refinements in Sarcoma Classification in the Current 2013…

read more

Anal Dysplasia

Sep 22, 2017 by in ONCOLOGY Comments Off on Anal Dysplasia

Anal dysplasia is a cytopathology term describing specific squamous cell morphology and represents a varying degree of benign changes. Often a source of confusion, the current iteration includes two types,…

read more

Epidemiology of Anal Canal Cancer

Sep 22, 2017 by in ONCOLOGY Comments Off on Epidemiology of Anal Canal Cancer

Anal cancer is a rare malignancy, although its incidence has been increasingly in recent decades. This article discusses risk factors for anal cancer and how these risk factors affect the…

read more

Nutritional Support in Esophagogastric Cancers

Sep 22, 2017 by in ONCOLOGY Comments Off on Nutritional Support in Esophagogastric Cancers

Esophageal and gastric cancers are common malignancies, both in the United States and worldwide, that carry significant morbidity and mortality. Malnutrition is a common complication in patients with esophageal and…

read more

Current Progress in Human Epidermal Growth Factor Receptor 2 Targeted Therapies in Esophagogastric Cancer

Sep 22, 2017 by in ONCOLOGY Comments Off on Current Progress in Human Epidermal Growth Factor Receptor 2 Targeted Therapies in Esophagogastric Cancer

Esophagogastric cancer is a worldwide health problem. The addition of the epidermal growth factor receptor 2 (HER2)-directed antibody trastuzumab to chemotherapy increased the overall survival of patients with metastatic HER2-positive…

read more
Get Clinical Tree app for offline access